Julie Johnson
Julie Johnson (D-TX) bought $1K-$15K of $MMM (3M Company Common Stock (MMM)) on Dec 18, 2025, part of 62 transactions in this filing.
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Suspicious Timing Detected
5 flagsRep. Julie Johnson bought $1,001 - $15,000 in $RSG on 2025-12-18, 8 days before S216 ("Save Our Seas 2.0 Amendments Act") was enacted, which could create new revenue streams for waste management.
Rep. Julie Johnson bought $1,001 - $15,000 in $PGR on 2025-12-18, 12 days before HR6934 ("National Flood Insurance Program Affordability Act") was enacted, which could provide graduated discounts on insurance.
Rep. Julie Johnson bought $1,001 - $15,000 in $MCD on 2025-12-18, 26 days before HR4366 ("Save Local Business Act") was enacted, which aims to reduce operational costs for businesses.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Date |
|---|---|---|---|---|
| BUY | $MMM | 3M Company Common Stock (MMM) | $1K-$15K | Dec 18, 2025 |
| BUY | $ABT | Abbott Laboratories Common Stock (ABT) | $1K-$15K | Dec 18, 2025 |
| BUY | $ABBV | AbbVie Inc. Common Stock (ABBV) | $1K-$15K | Dec 18, 2025 |
| BUY | $APD | Air Products and Chemicals, Inc. Common Stock (APD) | $1K-$15K | Dec 18, 2025 |
| BUY | $GOOG | Alphabet Inc. - Class C Capital Stock (GOOG) | $1K-$15K | Dec 18, 2025 |
| BUY | $AXP | American Express Company Common Stock (AXP) | $1K-$15K | Dec 18, 2025 |
| BUY | $ADI | Analog Devices, Inc. - Common Stock (ADI) | $1K-$15K | Dec 18, 2025 |
| BUY | $AJG | Arthur J. Gallagher & Co. Common Stock (AJG) | $1K-$15K | Dec 18, 2025 |
| BUY | $BAC | Bank of America Corporation Common Stock (BAC) | $1K-$15K | Dec 18, 2025 |
| BUY | $BX | Blackstone Inc. Common Stock (BX) | $1K-$15K | Dec 18, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Homeopathic Drug Product Safety, Quality, and Transparency Act
HR 7050 would end the FDA's long-standing enforcement discretion over homeopathic products and require individual pre-market approval for each product. For CHD, PG, and CLX, the affected product lines represent a small fraction of total revenue. The bill is at the earliest legislative stage and faces a long path to enactment. Market data shows no pricing of this risk: CHD is up 4.02% in 30 days, PG up 1.86%, CLX down 7.02% due to unrelated factors.
Power for the People Act of 2026
The Power for the People Act (S.3682) is an early-stage bill with zero funding and no near-term market impact. It targets data center electricity cost allocation, shifting infrastructure costs from residential ratepayers to operators. For utilities, the risk is structural but distant — only Entergy ($ETR) and NextEra's competitive arm ($NEE) face measurable downside if the bill advances, as their data center demand thesis is most priced in.
ACE Agriculture Act
The ACE Agriculture Act (HR7142) permanently authorizes AGARDA through FY2032 and expands its sustainability goals, but authorizes zero direct funding. This is a long-term policy signal for precision ag and water-saving tech, not a near-term catalyst. Recent stock moves for $DE, $AGCO, and $SMG show no correlation with this procedural bill.
Save Our Seas 2.0 Amendments Act
The Save Our Seas 2.0 Amendments Act was signed into law on December 26, 2025, reauthorizing NOAA's Marine Debris Program through FY2029 and adding new contracting and in-kind contribution authorities. However, the bill does not appropriate any specific funding, making its market impact negligible. Waste management and recycling companies ($WM, $RSG, $ECL) are structurally exposed to incremental federal procurement opportunities, but without an appropriations rider there is no material revenue catalyst.
National Flood Insurance Program Affordability Act
HR6934, the National Flood Insurance Program Affordability Act, is an early-stage bill with no appropriated funding, no legislative momentum, and no near-term market impact. Introduced by a junior House member and referred to committee in December 2025, it has had zero action in over four months. Insurer stocks ($ALL, $TRV, $CINF, $PGR) are trading near their 52-week highs, driven by other factors, and this bill presents no current risk or opportunity.
Save Local Business Act
The Save Local Business Act (HR4366), passed by the House on January 13, 2026, redefines joint employer liability to require direct and immediate control, structurally benefiting major franchisors McDonald's ($MCD), Yum! Brands ($YUM), and Domino's ($DPZ) by eliminating a multi-billion-dollar class-action litigation overhang. Despite significant 7-day stock weakness — DPZ down -10.76%, MCD down -4.12%, YUM down -0.55% — this legislative risk reduction is a direct margin and valuation catalyst once enacted. The bill awaits Senate action.
Dietary Supplement Listing Act of 2026
The Dietary Supplement Listing Act of 2026 (S.3677) is an early-stage bill that would require mandatory pre-market listing of dietary supplements with the FDA, increasing compliance costs across the industry. The bill is still in committee and faces a long legislative path. If enacted, pure-play supplement companies like Herbalife face margin pressure, while large diversified CPG companies like Kraft Heinz are relatively protected.
Public Integrity in Financial Prediction Markets Act of 2026
HR7004 prohibits federal officials from trading prediction market contracts, directly reducing the potential user base for platforms like CME Group's event contract market. The bill is in early legislative stages (referred to committee), with no near-term market impact. $CME trades at $287.01, down 2.82% in the last 30 days, with the event contract business representing a negligible portion of revenue.
Increasing Investor Opportunities Act
The Increasing Investor Opportunities Act (S.3671) removes SEC authority to restrict closed-end funds from investing in private funds and from listing those fund shares on exchanges. Private equity firms $BX and $KKR gain a new permanent capital source, while exchange operator $ICE (NYSE) directly benefits from increased listings. The bill is at an early stage (referred to committee), limiting near-term impact.
To amend section 495 of the Public Health Service Act to require inspections of foreign laboratories conducting biomedical and behavioral research to ensure compliance with applicable animal welfare requirements, and for other purposes.
HR7165 (WATCH Act) imposes quarterly inspection mandates on foreign labs conducting NIH-funded animal research, targeting CROs like IQVIA and CRL. Both stocks have declined sharply in the last week, with IQVI down 2.49% and CRL down 3.4% over 7 days, reflecting sector weakness amplified by this regulatory overhang. The bill is early-stage and authorized no new funding, but its compliance costs would pressure margins if enacted.
Other Filings by Julie Johnson
Free — no credit card
Get the next Johnson trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.